These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 8862583)

  • 1. Detection of hepatitis C virus by PCR in second-generation enzyme immunoassay-seropositive blood donors by using matched pairs of fresh frozen plasma and pilot tube sera.
    Krajden M; Zhao J; Bourke C; Scalia V; Gill P; Lau W
    J Clin Microbiol; 1996 Sep; 34(9):2191-5. PubMed ID: 8862583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnosis of hepatitis C virus in Brazilian blood donors using a reverse transcriptase nested polymerase chain reaction: comparison with enzyme immunoassay and recombinant protein immunoblot assay.
    Gonçales NS; Costa FF; Vassallo J; Gonçales FL
    Rev Inst Med Trop Sao Paulo; 2000; 42(5):263-7. PubMed ID: 11058936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Performance of second- and third-generation RIBAs for confirmation of third-generation HCV EIA-reactive blood donations. Retrovirus Epidemiology Donor Study.
    Tobler LH; Lee SR; Stramer SL; Peterson J; Kochesky R; Watanabe K; Quan S; Polito A; Busch MP
    Transfusion; 2000 Aug; 40(8):917-23. PubMed ID: 10960517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis C virus in blood samples from volunteer donors.
    Zhang HY; Kuramoto IK; Mamish D; Sazama K; Holland PV; Zeldis JB
    J Clin Microbiol; 1993 Mar; 31(3):606-9. PubMed ID: 8384627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of indeterminate c22-3 reactivity in volunteer blood donors.
    Tobler LH; Busch MP; Wilber J; Dinello R; Quan S; Polito A; Kochesky R; Bahl C; Nelles M; Lee SR
    Transfusion; 1994 Feb; 34(2):130-4. PubMed ID: 8310482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lookback on donors who are repeatedly reactive on first-generation hepatitis C virus assays:justification and rational implementation.
    Tobler LH; Tegtmeier G; Stramer SL; Quan S; Dockter J; Giachetti C; Busch MP
    Transfusion; 2000 Jan; 40(1):15-24. PubMed ID: 10644807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The significance of third-generation HCV RIBA-indeterminate, RNA-negative results in voluntary blood donors screened with sequential third-generation immunoassays.
    Kiely P; Kay D; Parker S; Piscitelli L
    Transfusion; 2004 Mar; 44(3):349-58. PubMed ID: 14996191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integration of nucleic acid amplification test results into hepatitis C virus supplemental serologic testing algorithms: implications for donor counseling and revision of existing algorithms.
    Kleinman SH; Stramer SL; Brodsky JP; Caglioti S; Busch MP
    Transfusion; 2006 May; 46(5):695-702. PubMed ID: 16686836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Supplementary anti-hepatitis C virus (HCV) testing with 2nd and 3rd generation recombinant immunoblot assay and matrix applied to enzyme immunoassay positive sera and comparison with HCV-RNA detection.
    Engel PM; Dennin RH
    Zentralbl Bakteriol; 1998 Oct; 288(2):267-75. PubMed ID: 9809407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of anti-hepatitis C virus antibodies in patients undergoing dialysis by utilizing a hepatitis C virus 3.0 assay: correlation with hepatitis C virus RNA.
    de Medina M; Hill M; Sullivan HO; Leclerq B; Pennell JP; Jeffers L; Reddy KR; Schiff ER; Perez GO
    J Lab Clin Med; 1998 Jul; 132(1):73-5. PubMed ID: 9665375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blood donors who are repeatedly reactive for hepatitis C virus on enzyme immunoassay and positive on recombinant immunoblot assay: evidence of failure to identify some risk factors.
    Moore SB; Kruger JR; Rakela J; Vamvakas EC; Schimek C; Germer JJ; Persing DH
    Transfusion; 1995 Apr; 35(4):308-12. PubMed ID: 7701548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Follow-up of six blood donors highlights the complementary role and limitations of hepatitis C virus antibody and nucleic acid amplification tests.
    Hyland C; Seed CR; Kiely P; Parker S; Cowley N; Bolton W
    Vox Sang; 2003 Jul; 85(1):1-8. PubMed ID: 12823724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-specific and specific anti-HCV results correlated to age, sex, transaminase, rhesus blood group and follow-up in blood donors.
    Caspari G; Gerlich WH; Beyer J; Schmitt H
    Arch Virol; 1997; 142(3):473-89. PubMed ID: 9349294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of second- and third-generation enzyme immunoassays for detecting antibodies to hepatitis C virus.
    Abdel-Hamid M; El-Daly M; El-Kafrawy S; Mikhail N; Strickland GT; Fix AD
    J Clin Microbiol; 2002 May; 40(5):1656-9. PubMed ID: 11980937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison between one first generation and three second generation anti-HCV ELISAs: an investigation in high- and low-risk subjects in correlation with recombinant immunoblot assay and polymerase chain reaction.
    Bååth L; Widell A; Nordenfelt E
    J Virol Methods; 1992 Dec; 40(3):287-96. PubMed ID: 1282130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis C virus RNA in blood donor sera detected by the polymerase chain reaction: comparison with supplementary hepatitis C antibody assays.
    Widell A; Månsson AS; Sundström G; Hansson BG; Nordenfelt E
    J Med Virol; 1991 Dec; 35(4):253-8. PubMed ID: 1724983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Routes of infection, viremia, and liver disease in blood donors found to have hepatitis C virus infection.
    Conry-Cantilena C; VanRaden M; Gibble J; Melpolder J; Shakil AO; Viladomiu L; Cheung L; DiBisceglie A; Hoofnagle J; Shih JW
    N Engl J Med; 1996 Jun; 334(26):1691-6. PubMed ID: 8637513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibodies to hepatitis C virus in autologous blood donors.
    Conover PT; Fang CT; Lam E; Hirschler NV; Jackson JB; Yomtovian RA
    Transfusion; 1991 Sep; 31(7):616-9. PubMed ID: 1654002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Second-generation hepatitis C Elisa antibody tests confirmed by the four-antigen recombinant immunoblot assay correlate well with hepatitis C viremia and chronic liver disease in Swedish blood donors.
    Shev S; Foberg U; Fryden A; Hermodsson S; Lindh G; Lindholm A; Månsson AS; von Sydow M; Weiland O; Widell A
    Vox Sang; 1993; 65(1):32-7. PubMed ID: 7689776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis C virus infection in hemodialysis patients: comparison of two new hepatitis C antibody assays with a second-generation assay.
    al Meshari K; Alfurayh O; Al Ahdal M; Qunibi W; Kessie G; De Vol E
    J Am Soc Nephrol; 1995 Nov; 6(5):1439-44. PubMed ID: 8589320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.